MASS
908 Devices·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 1
Ample Liquidity
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About MASS
908 Devices Inc.
A developer of analytical devices for chemical and biomolecular analysis and field forensic devices
Life Science Tools and Services
02/10/2012
12/18/2020
NASDAQ Stock Exchange
246
12-31
Common stock
44 Third Avenue
Burlington
MA 01803
--
908 Devices Inc., was incorporated in Delaware on February 10, 2012. The Company is a commercial-grade technology company that provides a suite of dedicated handheld and desktop mass spectrometers for the detection of unknown and invisible substances in a wide range of markets, including life science research, bioprocessing, industrial biotechnology, forensics and adjacent markets.
Earnings Call
Company Financials
EPS
MASS has released its 2025 Q3 earnings. EPS was reported at -0.41, versus the expected -0.12, missing expectations. The chart below visualizes how MASS has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
MASS has released its 2025 Q3 earnings report, with revenue of 14.01M, reflecting a YoY change of -3.54%, and net profit of -14.98M, showing a YoY change of 48.86%. The Sankey diagram below clearly presents MASS's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available


